Researchers have been studying the effects of Cannabidiol (“CBD”), a marijuana extract claimed by some to be a “wonder drug” for treating children who suffer from severe epilepsy. CBD, which has also been used in to treat many different conditions including schizophrenia and anxiety, has been legalized in many states and others are considering legislation.
Early research of CBD has revealed mixed results. For example, Dr. Kevin Chapman, a neurologist at Children’s Hospital Colorado conducted a study of 75 children treated with CBD. He found a drop in seizures by at least half in 33% of the children. But, also found that 44% of the children had a negative response that included an increase in seizures.
However, GW Pharmaceuticals (“GW”) conducted a study focused on a “purified CBD extract” known as Epidolex as part of their program to treat resistant childhood epilepsies. The study revealed that of 58 participants, 40% had a decline in seizures, 10% of which became completely seizure-free, while one patient had an increase in seizures. (read more about Epidiolex and GW Pharmaceuticals follow the link http://www.wsj.com/articles/PR-CO-20150108-905340)